Table 3.
Relative risk of overweight, obesity, and elevated androgens in the two studied groups
| Variable | PCOS women (study group) (n = 119) |
Non-PCOS controls (n = 118) |
Relative risk (95% CI); p-value |
|---|---|---|---|
| BMI 25-29.9 kg/m<sup>2</sup> BMI < 25 kg/m<sup>2</sup> |
53 (44.5) 66 (55.5) |
17 (14.4) 101 (85.6) |
3.1 (1.9-5.0); < 0.0001* |
| BMI ≥ 30 kg/m<sup>2</sup> BMI < 30 kg/m<sup>2</sup> |
42 (35.3) 77 (64.7) |
12 (10.2) 106 (89.8) |
3.5 (1.93-6.3); < 0.0001* |
| Waist circumference > 35 inches Waist circumference < 35 inches |
49 (41.2) 70 (58.8) |
15 (12.7) 103 (87.3) |
3.2 (1.9-5.4); < 0.0001* |
| Total testosterone > 86 ng/dl Total testosterone < 86 ng/dl |
83 (69.8) 36 (30.2) |
34 (28.8) 84 (71.2) |
2.4 (1.8-3.3); < 0.0001* |
| Free testosterone > 3.6 pg/ml Free testosterone < 3.6 pg/ml |
61 (51.3) 58 (48.7) |
21 (17.8) 97 (82.2) |
2.9 (1.9-4.4); < 0.0001* |
| Androstenedione > 3.1 ng/ml Androstenedione < 3.1 ng/ml |
55 (46.2) 64 (53.8) |
18 (15.3) 100 (84.7) |
3.0 (1.9-4.8); < 0.0001* |
| DHEA > 7780 ng/l DHEA < 7780 ng/l |
15 (12.6) 104 (87.4) |
13 (11.0) 105 (89.0) |
1.2 (0.59-2.4); 0.66 |
BMI – body mass index, DHEA – dehydroepiandrosterone, PCOS – polycystic ovary syndrome, CI – confidence interval. * Significant difference. Data presented as number and percentage (%)